FR2053000B1 - - Google Patents

Info

Publication number
FR2053000B1
FR2053000B1 FR7022992A FR7022992A FR2053000B1 FR 2053000 B1 FR2053000 B1 FR 2053000B1 FR 7022992 A FR7022992 A FR 7022992A FR 7022992 A FR7022992 A FR 7022992A FR 2053000 B1 FR2053000 B1 FR 2053000B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7022992A
Other languages
French (fr)
Other versions
FR2053000A1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44048725A external-priority patent/JPS4829124B1/ja
Priority claimed from JP44048724A external-priority patent/JPS4829123B1/ja
Priority claimed from JP44091718A external-priority patent/JPS4829126B1/ja
Priority claimed from JP45040656A external-priority patent/JPS4946055B1/ja
Application filed by RIKEN filed Critical RIKEN
Publication of FR2053000A1 publication Critical patent/FR2053000A1/fr
Application granted granted Critical
Publication of FR2053000B1 publication Critical patent/FR2053000B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/0428—Surface-modified nanoparticles, e.g. immuno-nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
    • H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
    • H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
    • H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
    • H01F1/36—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles
    • H01F1/37—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles in a bonding agent
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
    • H01F1/445—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids the magnetic component being a compound, e.g. Fe3O4

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Power Engineering (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Soft Magnetic Materials (AREA)
FR7022992A 1969-06-20 1970-06-22 Expired FR2053000B1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP44048725A JPS4829124B1 (cg-RX-API-DMAC10.html) 1969-06-20 1969-06-20
JP44048724A JPS4829123B1 (cg-RX-API-DMAC10.html) 1969-06-20 1969-06-20
JP44091718A JPS4829126B1 (cg-RX-API-DMAC10.html) 1969-11-15 1969-11-15
JP45040656A JPS4946055B1 (cg-RX-API-DMAC10.html) 1970-05-13 1970-05-13

Publications (2)

Publication Number Publication Date
FR2053000A1 FR2053000A1 (cg-RX-API-DMAC10.html) 1971-04-16
FR2053000B1 true FR2053000B1 (cg-RX-API-DMAC10.html) 1974-08-30

Family

ID=27460934

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7022992A Expired FR2053000B1 (cg-RX-API-DMAC10.html) 1969-06-20 1970-06-22

Country Status (4)

Country Link
US (1) US3832457A (cg-RX-API-DMAC10.html)
DE (1) DE2030690C3 (cg-RX-API-DMAC10.html)
FR (1) FR2053000B1 (cg-RX-API-DMAC10.html)
GB (1) GB1315391A (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310507A (en) * 1978-08-02 1982-01-12 Eastman Kodak Company Contrast agent for radiography
FR2508802A1 (fr) * 1981-07-03 1983-01-07 Thomson Csf Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4731239A (en) * 1983-01-10 1988-03-15 Gordon Robert T Method for enhancing NMR imaging; and diagnostic use
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
DE3484390D1 (de) * 1983-06-09 1991-05-08 Field Group Chemicals Kontrastmittel.
US5618514A (en) 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US5746999A (en) * 1984-11-23 1998-05-05 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
ATE74279T1 (de) * 1986-04-07 1992-04-15 Francois Dietlin In der tomo-densitometrie zu verwendende zusammensetzungen.
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
JPH06510759A (ja) * 1991-08-05 1994-12-01 マリンクロッド・インコーポレイテッド 造影剤として使用する重金属クラスター
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
WO2005046733A1 (en) * 2003-11-17 2005-05-26 Philips Intellectual Property & Standards Gmbh Contrast agent for medical imaging techniques and usage thereof
JP2006073991A (ja) * 2004-08-02 2006-03-16 Sony Corp 電磁波抑制材料、電磁波抑制デバイス、並びに電子機器
US9155646B2 (en) * 2006-04-27 2015-10-13 Brs Holdings, Llc Composite stent with bioremovable ceramic flakes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US970215A (en) * 1910-06-29 1910-09-13 Oscar Gros Preparation impermeable for roentgen rays.
FR750173A (fr) * 1933-01-31 1933-08-05 Procédé pour la préparation de suspensions aqueuses de sulfate de baryum destinées aux examens aux rayons chi et moyens pour la mise en oeuvre dudit procédé
GB657979A (en) * 1948-07-03 1951-10-03 Miles Lab Improvements in or relating to x-ray contrast mediums
US3592185A (en) * 1967-04-18 1971-07-13 Yeda Res & Dev Ferromagnetic contrast media and method of use

Also Published As

Publication number Publication date
DE2065532A1 (de) 1974-05-16
DE2030690A1 (de) 1971-01-07
FR2053000A1 (cg-RX-API-DMAC10.html) 1971-04-16
DE2030690B2 (de) 1973-11-15
US3832457A (en) 1974-08-27
DE2030690C3 (de) 1974-06-12
DE2065532B2 (de) 1976-07-01
GB1315391A (en) 1973-05-02

Similar Documents

Publication Publication Date Title
AU2270770A (cg-RX-API-DMAC10.html)
AU465413B2 (cg-RX-API-DMAC10.html)
AU429630B2 (cg-RX-API-DMAC10.html)
AU5461069A (cg-RX-API-DMAC10.html)
CS151546B2 (cg-RX-API-DMAC10.html)
AU5712069A (cg-RX-API-DMAC10.html)
AU417208B2 (cg-RX-API-DMAC10.html)
AU5113869A (cg-RX-API-DMAC10.html)
AU428074B2 (cg-RX-API-DMAC10.html)
AU442285B2 (cg-RX-API-DMAC10.html)
AU438128B2 (cg-RX-API-DMAC10.html)
AU442357B2 (cg-RX-API-DMAC10.html)
AU442380B2 (cg-RX-API-DMAC10.html)
AT308690B (cg-RX-API-DMAC10.html)
AU425297B2 (cg-RX-API-DMAC10.html)
AU442322B2 (cg-RX-API-DMAC10.html)
AU428129B2 (cg-RX-API-DMAC10.html)
AU470661B1 (cg-RX-API-DMAC10.html)
AU442535B2 (cg-RX-API-DMAC10.html)
AU6254169A (cg-RX-API-DMAC10.html)
AU6261969A (cg-RX-API-DMAC10.html)
AU4923469A (cg-RX-API-DMAC10.html)
AU6144869A (cg-RX-API-DMAC10.html)
AU6132869A (cg-RX-API-DMAC10.html)
CS153559B2 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
ST Notification of lapse